ArticleInternational journal of oncology2014

Combination of dasatinib and gemcitabine reduces the ALDH1A1 expression and the proliferation of gemcitabine-resistant pancreatic cancer MIA PaCa-2 cells.

Hong-Quan Duong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.